Prognostic Significance of N-Glycolyl GM3 Ganglioside Expression in Non-Small Cell Lung Carcinoma Patients: New Evidences

Table 6

Survival of NSCLC patients according to immunohistochemical profile.

Antigens expression	EGFR^+		NeuGcGM3^+
	EGF		EGFR		EGF
Negative/positive	−	+	−	+	−	+
% of cases	41.3	58.7	51.9	48.1	58.1	41.9
% 5-year survival rate	84.2	48.1	68.2	40.0	61.9	48.0
Median survival (months)	47.5	44.7	44.6	23.3	41.1	38.5
value	0.014		0.030		0.256

%, percentage; value, log-rank test. Bold value indicates statistical significance.